HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

In case you missed it: October 24 to October 28

Take a look at this week's top headlines.

Pregnancy-related homicides a public health priority to reduce maternal mortality rates

Women in the US are more likely to be murdered during pregnancy or soon after childbirth than to die from the country’s top 3 leading causes of maternal death—high blood pressure disorders, hemorrhage, or sepsis—according to research in The BMJ.

Abortion restrictions during COVID-19 pandemic

A study in the journal Contraception found that, within the first year of the COVID-19 pandemic in the US, abortion clinics in states with low or medium hostility to abortion were significantly more likely to embrace innovative medication abortion practices such as changing ultrasound requirements, offering telehealth or dispensing medications without a physical exam, compared to abortion clinics in states with high or extreme hostility to abortion.

American Gastroenterological Association releases guidelines for pharmacologic management of obesity

The American Gastroenterological Association has released new guidance outlining the organization’s stance on evidence-based approaches to management of obesity using the latest pharmacological interventions.

Cosmetic gynecology with the AUGS Publication Committee

Watch the latest interview in a series from members of the AUGS Publications Committee to hear from Bobby Garcia, MD, about new perspectives in cosmetic gynecology.

Title X clinics offer same quality of contraceptive counseling as private health care

Federal health programs that provide services to economic and racial minorities may have a reputation for providing less empathetic or patient-centered care than private health care institutions, but a new study shows that—at least in contraceptive counseling¬—that’s not the case.

Noninvasive screening and diagnostic tool for endometriosis

Researchers from the Feinstein Institute in Manhasset, New York, found single-cell RNA sequencing to be an effective and noninvasive way to screen for and diagnose patients with endometriosis.